Cargando…

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway

BACKGROUND: There is little evidence-based guidance on how to optimize methadone dosages among patients with opioid addiction undergoing methadone maintenance treatment (MMT). This study aims to investigate whether self-perceived opioid withdrawal symptoms, adverse effects, and self-reported substan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chalabianloo, Fatemeh, Fadnes, Lars Thore, Høiseth, Gudrun, Ohldieck, Christian, Vold, Jørn Henrik, Aas, Christer, Løberg, Else-Marie, Johansson, Kjell Arne, Bramness, Jørgen G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091668/ https://www.ncbi.nlm.nih.gov/pubmed/33941217 http://dx.doi.org/10.1186/s13011-021-00367-w

Ejemplares similares

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

"Influence of methadone on clopidogrel in addicts on methadone maintenance therapy" Drug interaction between methadone and clopidogrel
por: Fallah, Ferigol, et al.
Publicado: (2016)

Toward precision prescribing for methadone: Determinants of methadone deposition
por: Talal, Andrew H., et al.
Publicado: (2020)

Methadone-drugs interactions: possible causes of methadone-related deaths
por: Mijatović, Vesna, et al.
Publicado: (2012)

Scotland's 2009–2015 methadone-prescription cohort: Quintiles for daily dose of prescribed methadone and risk of methadone-specific death
por: Gao, Lu, et al.
Publicado: (2021)

Effects of Methadone on Liver Enzymes in Patients Undergoing Methadone Maintenance Treatment
por: Eslami-Shahrbabaki, Mahin, et al.
Publicado: (2012)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

Methadone Treatment at Forty
por: Marion, Ira J.
Publicado: (2005)

Methadone in Cancer Pain
por: Ramkiran, S, et al.
Publicado: (2020)

Brain/blood ratios of methadone and ABCB1 polymorphisms in methadone-related deaths
por: Iwersen-Bergmann, S., et al.
Publicado: (2021)

Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan
por: Li, Dian-Jeng, et al.
Publicado: (2018)

Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan
por: Lee, Hsin-Ya, et al.
Publicado: (2012)

The Correlation between Methadone Dosage and Comorbid Psychiatric Disorders in Patients on Methadone Maintenance Treatment
por: Parvaresh, Nooshin, et al.
Publicado: (2012)

Opioid tolerance in methadone maintenance treatment: comparison of methadone and levomethadone in long-term treatment
por: Gutwinski, Stefan, et al.
Publicado: (2016)

Investigating Cognitive Functions in Methadone Users in Comparison with Methadone and Methamphetamine Users and Control Group
por: Eslami-Shahrbabaki, Mahin, et al.
Publicado: (2022)

Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments
por: Ward, Clara, et al.
Publicado: (2020)

Inappropriate Conclusions Regarding Neurotoxicity in Methadone and Methamphetamine Users: Comment on “Investigating cognitive functions in methadone users in comparison with methadone and methamphetamine users and control group”
por: Erler, Jacqueline A, et al.
Publicado: (2023)

Use of benzodiazepines and detoxification with methadone
por: Popescu, G, et al.
Publicado: (2014)

Availability of outpatient methadone maintenance
por: Creedon, Timothy B, et al.
Publicado: (2015)

Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series
por: Lu, Wenjie J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_el73a9paoq0n2dn243hta8uvvo